Emma Scott

Associate Professor

  • 3390 Citations
  • 12 h-Index

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Emma Scott is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 7 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 3390 Citations
  • 12 h-Index
  • 17 Article
  • 2 Letter
  • 2 Review article

Outcomes of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody therapy

Gandhi, U. H., Cornell, R. F., Lakshman, A., Gahvari, Z. J., McGehee, E., Jagosky, M. H., Gupta, R., Varnado, W., Fiala, M. A., Chhabra, S., Malek, E., Mansour, J., Paul, B., Barnstead, A., Kodali, S., Neppalli, A., Liedtke, M., Narayana, S., Godby, K. N., Kang, Y. & 9 others, Kansagra, A., Umyarova, E., Scott, E. C., Hari, P., Vij, R., Usmani, S. Z., Callander, N. S., Kumar, S. K. & Costa, L. J., Sep 1 2019, In : Leukemia. 33, 9, p. 2266-2275 10 p.

Research output: Contribution to journalArticle

Open Access
  • 23 Scopus citations

    Revised International Staging System Is Predictive and Prognostic for Early Relapse (<24 months) after Autologous Transplantation for Newly Diagnosed Multiple Myeloma

    Gopalakrishnan, S., D'Souza, A., Scott, E., Fraser, R., Davila, O., Shah, N., Gale, R. P., Kamble, R., Diaz, M. A., Lazarus, H. M., Savani, B. N., Hildebrandt, G. C., Solh, M., Freytes, C. O., Lee, C., Kyle, R. A., Usmani, S. Z., Ganguly, S., Assal, A., Berdeja, J. & 14 others, Kanate, A. S., Dhakal, B., Meehan, K., Kindwall-Keller, T., Saad, A., Locke, F., Seo, S., Nishihori, T., Gergis, U., Gasparetto, C., Mark, T., Nieto, Y., Kumar, S. & Hari, P., Apr 2019, In : Biology of Blood and Marrow Transplantation. 25, 4, p. 683-688 6 p.

    Research output: Contribution to journalArticle

  • 5 Scopus citations

    Bortezomib-based Chemotherapy for Multiple Myeloma Patients Without Comorbid Cardiovascular Disease Shows No Cardiotoxicity

    Heitner, S. B., Minnier, J., Naher, A., Van Woerkom, R. C., Ritts, A., Ferencik, M., Broberg, C., Medvedova, E., Silbermann, R. & Scott, E. C., Dec 2018, In : Clinical Lymphoma, Myeloma and Leukemia. 18, 12, p. 796-802 7 p.

    Research output: Contribution to journalArticle

  • Daratumumab plus bortezomib and dexamethasone versus bortezomib and dexamethasone in relapsed or refractory multiple myeloma: Updated analysis of CASTOR

    Spencer, A., Lentzsch, S., Weisel, K., Avet-Loiseau, H., Mark, T. M., Spicka, I., Masszi, T., Lauri, B., Levin, M. D., Bosi, A., Hungria, V., Cavo, M., Lee, J. J., Nooka, A. K., Quach, H., Lee, C., Barreto, W., Corradini, P., Min, C. K., Scott, E. C. & 17 others, Chanan-Khan, A. A., Horvath, N., Capra, M., Beksac, M., Ovilla, R., Jo, J. C., Shin, H. J., Sonneveld, P., Soong, D., Casneuf, T., Chiu, C., Amin, H., Qi, M., Thiyagarajah, P., Sasser, A. K., Schecter, J. M. & Mateos, M. V., Nov 30 2018, In : Haematologica. 103, 12, p. 2079-2087 9 p.

    Research output: Contribution to journalArticle

  • 71 Scopus citations

    Efficacy and toxicity of therapy immediately after treatment with nivolumab in relapsed multiple myeloma

    Pianko, M. J., Funt, S. A., Page, D. B., Cattry, D., Scott, E. C., Ansell, S. M., Borrello, I. M., Gutierrez, M., Lendvai, N., Hassoun, H., Landgren, C. O. & Lesokhin, A. M., Jan 2 2018, In : Leukemia and Lymphoma. 59, 1, p. 221-224 4 p.

    Research output: Contribution to journalLetter

    5 Scopus citations